Made with ❤️ by True Sparrow

Bringing you the latest funding data

GenEdit

Last funding round

Raised
$24,000,000
Round
Unknown

Funding News (3)

Jan 24 2024Chemical & Engineering News

Startup details

GenEdit

GenEdit

GenEdit is a delivery startup specializing in polymer nanoparticles for targeted gene editing. The firm has developed a large library of hydrophilic polymer nanoparticles, known as NanoGalaxy, for delivering genetic material to specific tissues.
www.genedit.com
South San Francisco, California, United States
Established in 2016
11-50 People
Healthcare, Drug Discovery and Delivery

Founders

Kunwoo Lee

Kunwoo Lee

Chief Executive Officer & Co-founder

Berkeley, California, United States

Investment details

Raised
$24,000,000
Round
Unknown
Investors
Eli Lilly and Company
LEAD
Terra VC
Huons

Funding News (2)

Jan 23 2024The Pharma Letter
Jan 23 2024Global Genes

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United States

Apr2024
1

Today

VulnCheck raised a $8.0M Seed led by Sorenson Capital
Utah-based VulnCheck provides cyberthreat intelligence platform for predicting attack avenues and prioritizing vulnerabilities.
VulnCheck

Founders

Anthony Bettini,

Jacob Baines

In News

SiliconANGLE
2

Today

Spintly raised a $2M Seed from Accel and 2 others
US-based Spintly Inc. offers cloud-based smart building solutions for physical access control.
Spintly

Founders

Rohin Parkar

In News

Outlook Business & Money
3

1 day ago

XFactor raised a $16M Series A led by Accel and 1 other
San Francisco-based Xfactor.io empowers revenue leaders with AI-powered go-to-market automation.
XFactor

Founders

Mike Carpenter

In News

Yahoo Finance
4

1 day ago

Superlogic raised $7.6M from Chainlink and 5 others
Superlogic is a Blockchain-powered loyalty solutions provider empowering brands with next-gen technology.
Superlogic

Founders

Lin Dai

In News

Forbes
The Crypto Times
Globe Echo
5

1 day ago

Metsera raised $290M led by ARCH Ventures
New York-based Metsera is a clinical-stage biopharmaceutical company focused on developing medicines for obesity and metabolic diseases.
Metsera

Founders

Daniel Hoey,

Gbola Amusa

In News

FinSMEs
ET Pharma
Devdiscourse
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.